Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, B-Cell × Tubercidin × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, B-Cell 1

Interventions

Cyclophosphamide 44 Rituximab 31 fludarabine 27 Magnetic Resonance Spectroscopy 13 Doxorubicin 13 Specimen Handling 12 Prednisone 12 Bendamustine Hydrochloride 12 fludarabine phosphate 11 Vincristine 11 Etoposide 11 pirtobrutinib 10 obinutuzumab 9 Lenalidomide 9 Biopsy 8 venetoclax 7 polatuzumab vedotin 7 glofitamab 7 Immunotherapy, Adoptive 7 zanubrutinib 6 pembrolizumab 6 etoposide phosphate 6 tafasitamab 5 ibrutinib 5 acalabrutinib 5 Leukapheresis 5 Dexamethasone 5 Carboplatin 5 tazemetostat 4 loncastuximab tesirine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05991388 2026-02-20

Glo-BNHL

University of Birmingham

Phase 2/3 Recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡